Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade Gliomas
Status:
Withdrawn
Trial end date:
2018-02-01
Target enrollment:
Participant gender:
Summary
The investigators hypothesize that this study will show that sufficient lymphocyte stem cell
can be harvested prior chemoradiation and be reinfused back after treatment, and at least 5
of the 10 patients (50%) will achieve an absolute increase of lymphocyte counts of 300
cells/mm^3 four weeks after stem cell reinfusion in high grade glioma patients.